Skip to content

Silence Therapeutics plc

SLN· NasdaqCore metricsCIK 1479615

Pharmaceutical preparations552 peers

Last sale
Oct 30, 2026 · -0.18%
Market cap
$3.69B
186.61M shares
Filings
280
$0.00
Q3 2026−98.7% FY25 yoy
-$12.43M
Q3 2026N/M FY25 yoy
-$14.22M
Q3 2026N/M FY25 yoy
-$26.86M
Q3 2026derivedN/M FY25 yoy
-$0.08
Q3 2026N/M FY25 yoy
$247.66M
Q3 2026−90.7% FY25 yoy
$3.69B
—
8086.4×
17.1×
-1.20%
—

Twelve months to Sep 30, 2026 · derived

Price

$19.76+173.68%+$12.54past year
Oct 30, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$559.00KFY 2025
$43.26M0FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$559,000reported
FY 20242024-12-31$43,258,000reported
FY 20232023-12-31$31,643,000reported
FY 20222022-12-31$21,655,000reported

Segments

Revenue by Geography, FY2022 to FY2025FY2022UK · FY2022 · $20.94MGermany · FY2022 · $715.00KFY2023UK · FY2023 · $30.93MGermany · FY2023 · $709.00KFY2024UK · FY2024 · $43.11MGermany · FY2024 · $144.00KFY2025UK · FY2025 · $559.00K
LineFY2025ShareChange
UK$559.00K100%−98.7%
Germany———
Total$559.00K

From the 10-K filed Mar 5, 2026SLN

Pharmaceutical preparations

Silence Therapeutics plc is the 226th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Silence Therapeutics plc · CIK 1479615 · Engraved from SEC EDGAR